Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function

Abstract Parkinson’s disease (PD) is characterised by the degeneration of A9 dopaminergic neurons and the pathological accumulation of alpha-synuclein. The p.A30P SNCA mutation generates the pathogenic form of the alpha-synuclein protein causing an autosomal-dominant form of PD. There are limited st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peter A. Barbuti, Jochen Ohnmacht, Bruno F. R. Santos, Paul M. Antony, François Massart, Gérald Cruciani, Claire M. Dording, Lukas Pavelka, Nicolas Casadei, Yong-Jun Kwon, Rejko Krüger
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fa5d1e8ffb404e52b22f63112205442d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa5d1e8ffb404e52b22f63112205442d
record_format dspace
spelling oai:doaj.org-article:fa5d1e8ffb404e52b22f63112205442d2021-11-14T12:19:46ZGene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function10.1038/s41598-021-01505-x2045-2322https://doaj.org/article/fa5d1e8ffb404e52b22f63112205442d2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01505-xhttps://doaj.org/toc/2045-2322Abstract Parkinson’s disease (PD) is characterised by the degeneration of A9 dopaminergic neurons and the pathological accumulation of alpha-synuclein. The p.A30P SNCA mutation generates the pathogenic form of the alpha-synuclein protein causing an autosomal-dominant form of PD. There are limited studies assessing pathogenic SNCA mutations in patient-derived isogenic cell models. Here we provide a functional assessment of dopaminergic neurons derived from a patient harbouring the p.A30P SNCA mutation. Using two clonal gene-corrected isogenic cell lines we identified image-based phenotypes showing impaired neuritic processes. The pathological neurons displayed impaired neuronal activity, reduced mitochondrial respiration, an energy deficit, vulnerability to rotenone, and transcriptional alterations in lipid metabolism. Our data describes for the first time the mutation-only effect of the p.A30P SNCA mutation on neuronal function, supporting the use of isogenic cell lines in identifying image-based pathological phenotypes that can serve as an entry point for future disease-modifying compound screenings and drug discovery strategies.Peter A. BarbutiJochen OhnmachtBruno F. R. SantosPaul M. AntonyFrançois MassartGérald CrucianiClaire M. DordingLukas PavelkaNicolas CasadeiYong-Jun KwonRejko KrügerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Peter A. Barbuti
Jochen Ohnmacht
Bruno F. R. Santos
Paul M. Antony
François Massart
Gérald Cruciani
Claire M. Dording
Lukas Pavelka
Nicolas Casadei
Yong-Jun Kwon
Rejko Krüger
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
description Abstract Parkinson’s disease (PD) is characterised by the degeneration of A9 dopaminergic neurons and the pathological accumulation of alpha-synuclein. The p.A30P SNCA mutation generates the pathogenic form of the alpha-synuclein protein causing an autosomal-dominant form of PD. There are limited studies assessing pathogenic SNCA mutations in patient-derived isogenic cell models. Here we provide a functional assessment of dopaminergic neurons derived from a patient harbouring the p.A30P SNCA mutation. Using two clonal gene-corrected isogenic cell lines we identified image-based phenotypes showing impaired neuritic processes. The pathological neurons displayed impaired neuronal activity, reduced mitochondrial respiration, an energy deficit, vulnerability to rotenone, and transcriptional alterations in lipid metabolism. Our data describes for the first time the mutation-only effect of the p.A30P SNCA mutation on neuronal function, supporting the use of isogenic cell lines in identifying image-based pathological phenotypes that can serve as an entry point for future disease-modifying compound screenings and drug discovery strategies.
format article
author Peter A. Barbuti
Jochen Ohnmacht
Bruno F. R. Santos
Paul M. Antony
François Massart
Gérald Cruciani
Claire M. Dording
Lukas Pavelka
Nicolas Casadei
Yong-Jun Kwon
Rejko Krüger
author_facet Peter A. Barbuti
Jochen Ohnmacht
Bruno F. R. Santos
Paul M. Antony
François Massart
Gérald Cruciani
Claire M. Dording
Lukas Pavelka
Nicolas Casadei
Yong-Jun Kwon
Rejko Krüger
author_sort Peter A. Barbuti
title Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
title_short Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
title_full Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
title_fullStr Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
title_full_unstemmed Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
title_sort gene-corrected p.a30p snca patient-derived isogenic neurons rescue neuronal branching and function
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fa5d1e8ffb404e52b22f63112205442d
work_keys_str_mv AT peterabarbuti genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT jochenohnmacht genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT brunofrsantos genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT paulmantony genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT francoismassart genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT geraldcruciani genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT clairemdording genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT lukaspavelka genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT nicolascasadei genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT yongjunkwon genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
AT rejkokruger genecorrectedpa30psncapatientderivedisogenicneuronsrescueneuronalbranchingandfunction
_version_ 1718429326447214592